Note: All prices and reports are based on end of the day (EOD) data.
IPCA Laboratories Limited (IPCALAB)
What IPCALAB does

IPCA Laboratories Limited

What company does?Pharmaceutical manufacturing and marketing
Established1949
Entity typePrivate
HeadquartersIndia
SegmentB2B, B2C
IPCA Laboratories Limited is a share market listed company in the Pharmaceuticals industry . It got listed on NSE on 08-FEB-1995 under the trading symbol IPCALAB. On BSE it is listed under trading symbol IPCALAB. The company operates in Pharmaceuticals , Health Care and Biotechnology categories.

Company overview

IPCA Laboratories Limited is a leading pharmaceutical company in India, renowned for its focus on research and development, as well as the manufacture of high-quality active pharmaceutical ingredients (APIs) and formulations. The company has a robust presence in over 120 countries across the globe, with a diverse product portfolio covering various therapeutic segments such as anti-malarial, pain management, cardiovascular diseases, diabetes management, neurology, gastro-intestinal disorders, among others.

The company's innovative approach to drug development and manufacturing processes sets it apart from its competitors. IPCA Labs has invested significantly in state-of-the-art facilities that adhere to stringent quality standards and regulatory requirements set by global health authorities like USFDA (United States Food & Drug Administration), UK-MHRA (Medicines and Healthcare products Regulatory Agency), TGA Australia (Therapeutic Goods Administration), WHO-Geneva etc., which underlines their commitment to delivering safe and effective medications.

One of IPCA’s standout features is its strong emphasis on sustainability practices within its operations. It actively engages in environmental conservation efforts through initiatives aimed at reducing carbon emissions, water use efficiency improvement programs, waste reduction strategies while ensuring compliance with all applicable environmental regulations.

In terms of technological innovation, IPCA Labs leverages cutting-edge research capabilities to develop novel drug delivery systems and complex APIs that address unmet medical needs across different markets globally. This includes continuous investment into R&D activities focused on developing new chemical entities (NCEs) as part of their strategic growth plan.

Furthermore IPCA collaborates with various international partners for technology transfer agreements or joint ventures that enable them to expand their market reach effectively. These partnerships have proven instrumental in augmenting the company's capacity for producing niche API’s along with specialized formulations catering to specific patient populations worldwide – thereby bolstering their competitive edge within the industry.

Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.